CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH.
Hong JK, et al. Among authors: kim sc, kim eh, kim tw, kim dy, kim sm, kim j, kim mj.
Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657.
Anticancer Res. 2022.
PMID: 35346999